Immunogen (IMGN) Reports Resignation of CFO

November 26, 2018 4:02 PM

ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found